Search by Drug Name or NDC

    NDC 72789-0213-98 Abiraterone 250 mg/1 Details

    Abiraterone 250 mg/1

    Abiraterone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is ABIRATERONE ACETATE.

    Product Information

    NDC 72789-0213
    Product ID 72789-213_06348ed6-e295-6b48-e063-6294a90a4074
    Associated GPIs 21406010200320
    GCN Sequence Number 067349
    GCN Sequence Number Description abiraterone acetate TABLET 250 MG ORAL
    HIC3 V1J
    HIC3 Description ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
    GCN 29886
    HICL Sequence Number 037571
    HICL Sequence Number Description ABIRATERONE ACETATE
    Brand/Generic Generic
    Proprietary Name Abiraterone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Abiraterone acetate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name ABIRATERONE ACETATE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208339
    Listing Certified Through 2024-12-31

    Package

    NDC 72789-0213-98 (72789021398)

    NDC Package Code 72789-213-98
    Billing NDC 72789021398
    Package 120 TABLET in 1 BOTTLE, PLASTIC (72789-213-98)
    Marketing Start Date 2021-10-11
    NDC Exclude Flag N
    Pricing Information N/A